Cargando…
Statin therapy inhibits fatty acid synthase via dynamic protein modifications
Statins are a class of drug widely prescribed for the prevention of cardiovascular disease, with pleiotropic cellular effects. Statins inhibit HMG-CoA reductase (HMGCR), which converts the metabolite HMG-CoA into mevalonate. Recent discoveries have shown HMG-CoA is a reactive metabolite that can non...
Autores principales: | Trub, Alec G., Wagner, Gregory R., Anderson, Kristin A., Crown, Scott B., Zhang, Guo-Fang, Thompson, J. Will, Ilkayeva, Olga R., Stevens, Robert D., Grimsrud, Paul A., Kulkarni, Rhushikesh A., Backos, Donald S., Meier, Jordan L., Hirschey, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090928/ https://www.ncbi.nlm.nih.gov/pubmed/35538051 http://dx.doi.org/10.1038/s41467-022-30060-w |
Ejemplares similares
-
Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice
por: Bhatt, Dhaval P., et al.
Publicado: (2022) -
Remodeling of the Acetylproteome by SIRT3 Manipulation Fails to Affect Insulin Secretion or β Cell Metabolism in the Absence of Overnutrition
por: Peterson, Brett S., et al.
Publicado: (2018) -
Respiratory Phenomics across Multiple Models of Protein Hyperacylation in Cardiac Mitochondria Reveals a Marginal
Impact on Bioenergetics
por: Fisher-Wellman, Kelsey H., et al.
Publicado: (2019) -
Bioorthogonal pro-metabolites for profiling short chain fatty acylation
por: Sinclair, Wilson R., et al.
Publicado: (2017) -
Loss of SIRT3 leads to a compensatory shift in cellular metabolism promoting cancer cell growth
por: McDonnell, Eoin, et al.
Publicado: (2014)